GE HealthCare Receives FDA Clearances for Next-Gen MRI Systems and Diagnostic Viewer

GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for View, a next-generation diagnostic viewer within its Genesis Radiology Workspace. The company also announced FDA clearance for a trio of new MRI offerings: the Signa Sprint with Freelium, Signa Bolt and Signa One.

View is a cloud-native software application designed to support healthcare professionals in the display, processing and analysis of medical image data and clinical reports. The system was engineered to optimize the radiology workspace by empowering diagnosticians to work from virtually anywhere with full diagnostic confidence. The zero-footprint viewer serves as the core anchor of the Genesis platform.

The system streamlines standard and advanced imaging analysis and visualization by providing a complete suite of AI-enabled tools intended to generate relevant findings and aid clinical decision making. View also includes specialized support for breast imaging. By combining 2D imaging, basic 3D visualization and advanced image analysis into one interface, the system simplifies information access, improves workflow efficiency and reduces the need for multiple applications.

View's key features include a smart reading protocol which uses machine learning for creating and applying hanging protocols, AI workflow to support both DICOM Secondary Capture Object and DICOM Structured Report for displaying AI findings and enabling rejection/modification of those findings as well as access to 2D, 3D and history comparison exams in customizable layouts. The system offers direct access to GE HealthCare's Advanced Visualization applications for deeper analysis in a single workflow and enhanced access for DICOM images stored in the cloud server and access to breast images through the cloud with specific tools for mammogram images.

When GE HealthCare unveiled its Genesis Radiology Workspace in November 2025, View was pending 510(k) clearance. View's smart reading protocol function was tested on various imaging modality datasets representative of the clinical scenarios where it's intended to be used. A comparison was performed between the predicate device and View, where the data showed both devices to be equivalent.

The FDA cleared the Signa Sprint, a 1.5T sealed magnet MRI system, while Signa Bolt is an advanced 3T MRI scanner. Signa One offers an AI-driven ecosystem of workflow solutions designed to help reduce inefficiencies and support MRI exams from plan to scan and beyond. GE HealthCare submitted these offerings to the FDA for evaluation in December 2025.

Signa Sprint with Freelium offers helium-free technology without compromising clinical or operational efficiency. It supports strong image quality and clarity and integrates with deep learning solutions like Air Recon DL and Sonic DL. The system offers a wide coverage of anatomies and clinical applications. It offers the same power infrastructure as current conventional magnets and features a ventless magnet that enables installation virtually anywhere. The system also introduces two levels of operational autonomy. Scanning autonomy simplifies workflows, while autonomous magnet monitoring provides protection and recovery through intelligent sensors.

Signa Bolt offers the company's most advanced high-field, clinical wide bore 3.0T MRI system. The company said it combines ultra-high gradient performance, intelligent digital radiofrequency (RF) architecture and sustainable design to deliver precision imaging, fast workflows and seamless clinical-to-research flexibility. GE HealthCare says it achieves all this with low energy consumption and operational costs.

Signa One powers both of the newly cleared platforms, improving the imaging experience and streamlining MRI operations. It offers an intuitive experience that can help reduce training time and aims to boost productivity while shortening the learning curve. Its Signa One table enhances patient comfort and simplifies patient transport. The fully automated Signa One camera features in-room console live feeds, AI-enabled landmark localization and patient positioning verification. It has real-time visual guidance on a touchscreen display to improve speed and accuracy. The system also has contactless respiratory and peripheral gating to capture physiological data effortlessly, regardless of patient orientation. High-resolution, in-room consoles empower technologists with simple patient setup control.

GE HealthCare said it integrated its platforms with Nvidia technology to enhance the performance and intelligence of MR. It utilized Nvidia's RTX product line and Signa One to power Signa Bolt and Sprint.